Universal Biosensors Inc (ASX: UBI) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Universal Biosensors Inc. Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $157.31 million
P/E Ratio 0.78
Dividend Yield N/A
Shares Outstanding 177.75 million
Earnings per share -0.030
Dividend per share N/A
Year To Date Return 106.90%
Earnings Yield 128.47%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Universal Biosensors Inc (ASX: UBI)
Latest News

UBI ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Universal Biosensors Inc

Universal Biosensors Inc (UBI) is a medical diagnostics company. The company focused on the research, development, and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. Its OneTouch Verio is the first blood glucose product launched by LifeScan that uses the opposing electrode technology developed by Universal Biosensors. UBI is developing an immunoassay-based system (an important technique for biomarker measurement), which is progressing through the feasibility stage of the company's R&D pipeline. Geographically, the company gets a major share of its revenue from Switzerland.

UBI Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
26 Nov 2021 $0.90 $0.00 0.00% 207,414 $0.91 $0.92 $0.89
25 Nov 2021 $0.90 $-0.02 -2.19% 210,563 $0.92 $0.92 $0.90
24 Nov 2021 $0.92 $0.03 3.37% 440,008 $0.89 $0.93 $0.89
23 Nov 2021 $0.89 $-0.01 -1.11% 142,007 $0.91 $0.91 $0.86
22 Nov 2021 $0.90 $-0.03 -3.23% 95,546 $0.93 $0.93 $0.90
19 Nov 2021 $0.93 $-0.03 -3.11% 372,338 $0.97 $0.97 $0.93
18 Nov 2021 $0.97 $-0.02 -2.04% 360,214 $1.00 $1.02 $0.97
17 Nov 2021 $0.98 $0.07 7.65% 863,388 $0.94 $1.04 $0.94
16 Nov 2021 $0.92 $-0.01 -1.08% 269,508 $0.93 $0.93 $0.91
15 Nov 2021 $0.93 $0.07 8.14% 381,489 $0.89 $0.94 $0.89
12 Nov 2021 $0.86 $0.05 6.17% 226,332 $0.88 $0.88 $0.83
11 Nov 2021 $0.81 $0.02 2.52% 641,059 $0.80 $0.84 $0.80
10 Nov 2021 $0.80 $0.03 3.90% 1,256,826 $0.80 $0.81 $0.80
09 Nov 2021 $0.77 $-0.01 -1.29% 530,888 $0.78 $0.81 $0.77
08 Nov 2021 $0.78 $0.03 4.00% 232,651 $0.75 $0.82 $0.75
05 Nov 2021 $0.75 $-0.04 -5.10% 421,061 $0.77 $0.77 $0.73
04 Nov 2021 $0.79 $0.03 3.95% 66,598 $0.78 $0.79 $0.77
03 Nov 2021 $0.76 $0.03 4.11% 184,978 $0.74 $0.76 $0.74
02 Nov 2021 $0.73 $-0.02 -2.68% 48,304 $0.75 $0.75 $0.73
01 Nov 2021 $0.75 $0.01 1.35% 996,043 $0.75 $0.75 $0.72

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
05 Nov 2021 Craig Coleman Buy 1 $1,015,577
On-market trade. CDIs
07 Jan 2021 Craig Coleman Sell 12 $6,719,123
Ceased association with an entity.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Craig Evan Coleman Non-Executive DirectorNon-Executive Chairman Jun 2016
Mr Coleman is an experienced investment and funds management executive. His career of 30 years has spanned banking and finance, corporate advisory and funds management. Craig is currently the Executive Chairman of Viburnam Funds. During his executive career, Mr Coleman has held a number of senior executive positions with ANZ Banking Group Ltd, including Managing Director Banking Products, Managing Director Wealth Management, Non-Executive Director E TRADE Australia Ltd and Head of Retail Banking New Zealand. Mr Coleman currently retains non-executive directorship position with publicly listed entity Bell Financial Group Limited and is Chairman of Pacific Star Network Limited.
Ms Judith Ann Smith Non-Executive Director Mar 2015
Ms Smith is experienced investment and funds management executive. During her career, Ms Smith has worked in a number of investment management roles in the funds management industry, where she has been responsible for evaluating and investing in listed and unlisted companies. Ms Smith was formerly the Head of Private Equity at IFM Investors and Chair of the IFM Risk Committee. Ms Smith was also a member of the IFM Investments Committee, a role she has retained following her retirement from the firm. Prior to her role at IFM, Ms Smith held various investment management roles including more than a decade at National Mutual Funds Management Ltd (NMFM). At NMFM, she managed Australian equity research and strategy, as well as Australian equity portfolios. Ms Smith is a member of the Audit Committee of the Australian Renewable Energy Authority. She also serves as a director and Chairperson of the Audit Committee of Acorn Capital Investment Fund Ltd (ASX:ACQ). She is a trustee director of industry superannuation fund, LUCRF and the Chairperson of the LUCRF Investment Committee. She is a member of the advisory committee for the SA Venture Capital Fund. She is also a board member of Scale Investors Ltd. In July 2018, Ms Smith was appointed to the board of Funds S4.
Mr Salesh Balak Chief Financial OfficerCompany Secretary Dec 2018
-
Mr John Stewart Sharman Chief Executive Officer Jun 2020
-
John Stewart Sharman Chief Executive Officer
-
Salesh Balak Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Not disclosed in Annual Report 0 0.00%

Profile

since

Note